Literature DB >> 26413138

A bright future for bioluminescent imaging in viral research.

Stewart M Coleman1, Alistair McGregor1.   

Abstract

Bioluminescence imaging (BLI) has emerged as a powerful tool in the study of animal models of viral disease. BLI enables real-time in vivo study of viral infection, host immune response and the efficacy of intervention strategies. Substrate dependent light emitting luciferase enzyme when incorporated into a virus as a reporter gene enables detection of bioluminescence from infected cells using sensitive charge-coupled device (CCD) camera systems. Advantages of BLI include low background, real-time tracking of infection in the same animal and reduction in the requirement for larger animal numbers. Transgenic luciferase-tagged mice enable the use of pre-existing nontagged viruses in BLI studies. Continued development in luciferase reporter genes, substrates, transgenic animals and imaging systems will greatly enhance future BLI strategies in viral research.

Entities:  

Keywords:  BLI; CCD camera; bioluminescence imaging; cytomegalovirus; herpes simplex; influenza; luciferase; pathogenesis; viral dissemination; virus imaging

Year:  2015        PMID: 26413138      PMCID: PMC4581531          DOI: 10.2217/fvl.14.96

Source DB:  PubMed          Journal:  Future Virol        ISSN: 1746-0794            Impact factor:   1.831


  92 in total

1.  A secreted luciferase for ex vivo monitoring of in vivo processes.

Authors:  Thomas Wurdinger; Christian Badr; Lisa Pike; Ruben de Kleine; Ralph Weissleder; Xandra O Breakefield; Bakhos A Tannous
Journal:  Nat Methods       Date:  2008-01-20       Impact factor: 28.547

2.  Design and testing of novel oncolytic vaccinia strains.

Authors:  Steve H Thorne
Journal:  Methods Mol Biol       Date:  2009

3.  Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.

Authors:  John W Schoggins; Marcus Dorner; Michael Feulner; Naoko Imanaka; Mary Y Murphy; Alexander Ploss; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

4.  Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors.

Authors:  Xueqing Lun; Yibing Ruan; Aarthi Jayanthan; David J Liu; Anjali Singh; Tanya Trippett; John Bell; Peter Forsyth; Randal N Johnston; Aru Narendran
Journal:  Mol Oncol       Date:  2013-06-14       Impact factor: 6.603

5.  In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies.

Authors:  Nicholas S Heaton; Victor H Leyva-Grado; Gene S Tan; Dirk Eggink; Rong Hai; Peter Palese
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

6.  Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak.

Authors:  Christina L Hutson; Kemba N Lee; Jason Abel; Darin S Carroll; Joel M Montgomery; Victoria A Olson; Yu Li; Whitni Davidson; Christine Hughes; Michael Dillon; Paul Spurlock; James J Kazmierczak; Connie Austin; Lori Miser; Faye E Sorhage; James Howell; Jeffrey P Davis; Mary G Reynolds; Zachary Braden; Kevin L Karem; Inger K Damon; Russell L Regnery
Journal:  Am J Trop Med Hyg       Date:  2007-04       Impact factor: 2.345

7.  NanoLuc reporter for dual luciferase imaging in living animals.

Authors:  Amanda C Stacer; Shyam Nyati; Pranav Moudgil; Rahul Iyengar; Kathryn E Luker; Alnawaz Rehemtulla; Gary D Luker
Journal:  Mol Imaging       Date:  2013-10       Impact factor: 4.488

8.  A genetically humanized mouse model for hepatitis C virus infection.

Authors:  Marcus Dorner; Joshua A Horwitz; Justin B Robbins; Walter T Barry; Qian Feng; Kathy Mu; Christopher T Jones; John W Schoggins; Maria Teresa Catanese; Dennis R Burton; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

9.  Inhibition of firefly luciferase by general anesthetics: effect on in vitro and in vivo bioluminescence imaging.

Authors:  Marleen Keyaerts; Isabel Remory; Vicky Caveliers; Karine Breckpot; Tomas J Bos; Jan Poelaert; Axel Bossuyt; Tony Lahoutte
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

10.  Murine alveolar macrophages limit replication of vaccinia virus.

Authors:  Rachel Rivera; Martha Hutchens; Kathryn E Luker; Joanne Sonstein; Jeffrey L Curtis; Gary D Luker
Journal:  Virology       Date:  2007-02-27       Impact factor: 3.616

View more
  12 in total

1.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Effects of Chronic Diurnal Disruption and Acute Inflammatory Challenge on Mice with Latent Murine Gammaherpesvirus Infection.

Authors:  Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

3.  4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.

Authors:  Julien Sourimant; Carolin M Lieber; Megha Aggarwal; Robert M Cox; Josef D Wolf; Jeong-Joong Yoon; Mart Toots; Chengin Ye; Zachary Sticher; Alexander A Kolykhalov; Luis Martinez-Sobrido; Gregory R Bluemling; Michael G Natchus; George R Painter; Richard K Plemper
Journal:  Science       Date:  2021-12-02       Impact factor: 63.714

4.  A replication-competent foot-and-mouth disease virus expressing a luciferase reporter.

Authors:  Fuquan Zhang; Eva Perez-Martin; Nick Juleff; Bryan Charleston; Julian Seago
Journal:  J Virol Methods       Date:  2017-05-19       Impact factor: 2.014

Review 5.  Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges.

Authors:  Shyambabu Chaurasiya; Yuman Fong; Susanne G Warner
Journal:  Cancers (Basel)       Date:  2020-06-26       Impact factor: 6.639

6.  In Vivo Bioluminescence Imaging for Targeting Acute Hypoxic/Ischemic Small Intestine with Engineered Salmonella typhimurium.

Authors:  Chung-Man Moon; Jin Hai Zheng; Jung-Joon Min; Yong Yeon Jeong; Suk-Hee Heo; Sang-Soo Shin
Journal:  Mol Ther Methods Clin Dev       Date:  2020-06-25       Impact factor: 6.698

7.  Evaluation of chemical chaperones based on the monitoring of Bip promoter activity and visualization of extracellular vesicles by real-time bioluminescence imaging.

Authors:  Tomohisa Horibe; Nanako Okushima; Aya Torisawa; Ryutaro Akiyoshi; Yoko Hatta-Ohashi; Hirobumi Suzuki; Koji Kawakami
Journal:  Luminescence       Date:  2017-09-20       Impact factor: 2.464

8.  Bioluminescent Ross River Virus Allows Live Monitoring of Acute and Long-Term Alphaviral Infection by In Vivo Imaging.

Authors:  Essia Belarbi; Vincent Legros; Justine Basset; Philippe Desprès; Pierre Roques; Valérie Choumet
Journal:  Viruses       Date:  2019-06-27       Impact factor: 5.048

Review 9.  The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.

Authors:  Adrian Pelin; Jiahu Wang; John Bell; Fabrice Le Boeuf
Journal:  Oncolytic Virother       Date:  2018-03-28

10.  A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase.

Authors:  Ping Li; Qinghua Cui; Lin Wang; Xiujuan Zhao; Yingying Zhang; Balaji Manicassamy; Yong Yang; Lijun Rong; Ruikun Du
Journal:  Viruses       Date:  2018-06-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.